Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 951.97k | 216.85% |
| Gross profit | 951.97k | - |
| Net profit | -10.49m | 10.29% |
| EBITDA | -10.26m | 8.82% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €17.27m |
Number of shares | 65.8m |
52-week high/low | €3.13 - €0.17 |
| Dividends | No |
Beta | 0.02 |
P/E ratio | -0.39 |
PEG ratio | 0.01 |
P/B ratio | 0.95 |
P/S ratio | 4.80 |
Company profile
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.
| Name | BioInvent International |
| CEO | Martin Welschof |
| Headquarters | Lund,
sn Sweden |
| Website | |
| IPO | 12/06/2001 |
| Employees | 107 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Sto | BINV.ST |
Pnk | BOVNF |
Frankfurt | BIX0.F |
Düsseldorf | BIX0.DU |
London | 0H22.L |
Stockholm | BINV.ST |
München | BIX0.MU |